1 Unidad de Investigación, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
2 GEENDIAB (Grupo Español para el estudio de la Nefropatía Diabética), Sociedad Española de Nefrología, Santander, Spain.
3 Instituto de Tecnologías Biomédicas, University of La Laguna, Santa Cruz de Tenerife, Spain.
4 Doctoral and Graduate School, University of La Laguna, San Cristóbal de La Laguna, Tenerife, Spain.
5 Instituto de Investigación Sanitaria Fundación Jiménez-Díaz-Universidad Autónoma de Madrid, Madrid, Spain.
6 RICORS2040 (Red de Investigación Renal-RD21/0005/0013), Instituto de Salud Carlos III, Madrid, Spain.
Received 11 April 2022. Revision received 1 July 2022.
Accepted 1 July 2022.
A.O. has received grants from Sanofi and consultancy or speaker fees or travel support from Advicciene, Astellas, AstraZeneca, Amicus, Amgen, Fresenius Medical Care, GSK, Bayer, Sanofi-Genzyme, Menarini, Kyowa Kirin, Alexion, Idorsia, Chiesi, Otsuka, Novo-Nordisk, and Vifor Fresenius Medical Care Renal Pharma and is Director of the Catedra Mundipharma-UAM of diabetic kidney disease and the Catedra Astrazeneca-UAM of chronic kidney disease and electrolytes. A.O. is the Editor-in-Chief for CKJ. B.F.F. reports speaker fees or travel support from AbbVie, AstraZeneca, Boehringer Ingelheim, Esteve, Menarini, Mundipharma, Novartis, and Novo Nordisk. J.F.N.-G. has served as a consultant and has received speaker fees or travel support from AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Esteve, Eli Lilly, MSD, Mundipharma, Novartis, NovoNordisk, Sanofi-Genzyme, Servier, Shire, and Vifor Pharma. The other authors declare no conflicts of interest.
This work was supported by PI21/01037 -Instituto de Salud Carlos III (ISCIII)- and PIFIISC21/08 -Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC). J.D.-C. is the recipient of a contract from Miguel Servet Program (CP20/00122) of ISCIII. A.G.-L. is recipient of a contract from Agencia Canaria de Investigación Innovación y Sociedad de la Información del Gobierno de Canarias (ACIISI) (TESIS2021010045).
J.D.-C., E.M.-P., A.G.-L., A.M.-O., A.O., C.M.-F., and J.F.N.-G. did substantial contributions to the conception or design of the work or interpretation of data for the work. All authors contributed to the draft of the work or revised it critically for important intellectual content. J.D.-C., C.M.-F., and J.F.N.-G. did final approval of the version to be published. All authors agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
J.D.-C. and E.M.-P. have contributed equally to this work. Also, J.D.-C. and E.M.-P. share first authorship. J.D.-C., C.M.-F., and J.F.N.-G. share senior authorship.
Supplemental Visual Abstract; https://links.lww.com/TP/C559.
Supplemental digital content (SDC) is available for this article. Direct URL citations appear in the printed text, and links to the digital files are provided in the HTML text of this article on the journal’s Web site (www.transplantjournal.com).
Correspondence: Javier Donate-Correa, PhD. Research Unit Service, University Hospital Nuestra Señora de Candelaria. Santa Cruz de Tenerife, 38010, Spain. ([email protected]).